Direct Visualization of 3-Dimensional Force and Energy Map of a Single Molecular Switch

Mechanical properties of molecules adsorbed on materials surfaces are increasingly vital for the applications of molecular thin films. Here, we conduct a fundamental research to induce conformational change mechanically on a single molecule and quantify the driving force needed for such molecular shape switch via a low temperature (~ 5K) Scanning Tunneling Microscope (STM) and Qplus Atomic Force Microscope (Q+AFM). Our measurement maps a three-dimensional landscape for mechanical potential and force at single molecule level with high spatial resolution in all three dimensions of a few angstrom (10-10 m). Molecule TBrPP-Co (a cobalt porphyrin) deposited on an atomically clean gold substrate typically has two of its pentagon rings tilted upward and the other two downward. An atomically sharp tip of the STM/Q+AFM, which vibrates with a high frequency (~ 30kHz), is employed to scan the molecule at different heights with 0.1Å increment and meanwhile record tip-molecule interaction strength in the form of tip frequency change. When tip approaches to the threshold distance to the molecule, mechanical force become large enough and cause pentagon rings flip their direction. Due to the sensitive nature of tip-molecule interaction, the rings flipping can be directly visualized by STM, as rings tilting upward exhibit two bright protrusions in contrast to rings downward in image. By processing frequency change, we obtain a three-dimensional mechanical potential and force map for a single molecule with the resolution of angstrom level in all three dimensions. Our preliminary results indicate that an energy barrier of ~400meV needs to be overcome for rings flipping of TBrPP-Co.https://digitalcommons.odu.edu/gradposters2021_sciences/1015/thumbnail.jp

Confirmation of Skywalker Hoolock Gibbon (Hoolock tianxing) in Myanmar extends known geographic range of an endangered primate

Characterizing genetically distinct populations of primates is important for protecting biodiversity and effectively allocating conservation resources. Skywalker gibbons (Hoolock tianxing) were first described in 2017, with the only confirmed population consisting of 150 individuals in Mt. Gaoligong, Yunnan Province, China. Based on river geography, the distribution of the skywalker gibbon has been hypothesized to extend into Myanmar between the N’Mai Kha and Ayeyarwaddy Rivers to the west, and the Salween River (named the Thanlwin River in Myanmar and Nujiang River in China) to the east. We conducted acoustic point-count sampling surveys, collected noninvasive samples for molecular mitochondrial cytochrome b gene identification, and took photographs for morphological identification at six sites in Kachin State and three sites in Shan State to determine the presence of skywalker gibbons in predicted suitable forest areas in Myanmar. We also conducted 50 semistructured interviews with members of communities surrounding gibbon range forests to understand potential threats. In Kachin State, we audio-recorded 23 gibbon groups with group densities ranging between 0.57 and 3.6 group/km2. In Shan State, we audio-recorded 21 gibbon groups with group densities ranging between 0.134 and 1.0 group/km2. Based on genetic data obtained from skin and saliva samples, the gibbons were identified as skywalker gibbons (99.54–100% identity). Although these findings increase the species’ known population size and confirmed distribution, skywalker gibbons in Myanmar are threatened by local habitat loss, degradation, and fragmentation. Most of the skywalker gibbon population in Myanmar exists outside protected areas. Therefore, the IUCN Red List status of the skywalker gibbon should remain as Endangered

Adherence to Artemisinin-based Combination Therapy for the Treatment of Malaria: A Systematic Review of the Evidence.

Increasing access to and targeting of artemisinin-based combination therapy (ACT) is a key component of malaria control programmes. To maximize efficacy of ACT and ensure adequate treatment outcomes, patient and caregiver adherence to treatment guidelines is essential. This review summarizes the current evidence base on ACT adherence, including definitions, measurement methods, and associated factors. A systematic search of the published literature was undertaken in November 2012 and updated in April 2013. Bibliographies of manuscripts were also searched and additional references identified. Studies were included if they involved at least one form of ACT and reported an adherence measurement. The search yielded 1,412 records, 37 of which were found to measure adherence to ACT. Methods to measure adherence focused on self-report, pill counts and bioassays with varying definitions for adherence. Most studies only reported whether medication regimens were completed, but did not assess how the treatment was taken by the patient (i.e. timing, frequency and dose). Adherence data were available for four different ACT formulations: artemether-lumefantrine (AL) (range 39-100%), amodiaquine plus artesunate (AQ + AS) (range 48-94%), artesunate plus sulphadoxine-pyrimethamine (AS + SP) (range 39-75%) and artesunate plus mefloquine (AS + MQ) (range 77-95%). Association between demographic factors, such as age, gender, education and socio-economic status and adherence to ACT regimens was not consistent. Some evidence of positive association between adherence and patient age, caregiver education levels, drug preferences, health worker instructions, patient/caregiver knowledge and drug packaging were also observed. This review highlights the weak evidence base on ACT adherence. Results suggest that ACT adherence levels varied substantially between study populations, but comparison between studies was challenging due to differences in study design, definitions, and methods used to measure adherence. Standardising methodologies for both self-report and bioassays used for evaluating adherence of different formulations across diverse contexts would improve the evidence base on ACT adherence and effectiveness; namely, specific and measurable definitions for adherence are needed for both methodologies. Additionally, further studies of the individual factors and barriers associated with non-adherence to ACT are needed in order to make informed policy choices and to improve the delivery of effective malaria treatment

Application of dengue diagnostic tests as point-of-care testing by Myanmar General Practitioners: did young GPs use more than senior GPs?

Background: Early detection of dengue cases via general practitioners (GPs), major primary care providers is an effective strategy in mitigation of dengue burden in Myanmar. Confirmation of dengue cases using laboratory tests is recommended by W.H.O for clinical management, prevention and control activities. Nevertheless, evidence on dengue diagnostic tests used by Myanmar GPs as point-of-care testing (POCT) has not been founded yet. Objective: To compare dengue diagnostic tests used as POCT between young GPs and senior GPs Methods: A cross-sectional descriptive and analytical study was conducted in August, 2015 among 72 GPs in Yangon. A pre-tested questionnaire was used to collect data regarding demo-academic and practice-background, dengue diagnostic tests used for POCT and its reasons. GPs aged under 30 years and currently practiced for 1-5 years as young GPs and their counter-part were defined as senior GPs for inferential analysis. Results: Young GPs and senior GPs were 35% (25/72) and 24% (17 /72) respectively while others 41% (30/72) were in-active in practice and did not meet with young-senior GPs definition. Dengue diagnostic tests application was still limited in GPs’ clinics. NS1-RDT (20.8%) was mostly used followed by Hess’s test (19.4%), NS1+IgM/IgG-RDT(18.1%),IgM/IgG-RDT(16.7%),WHO-clinical-criteria+NS1+ IgM/IgM-RTD+ Out-break information (16.7%) and WHO-clinical-criteria+NS1+ IgM/IgG-RDT(11.2%). Although both young and senior GPs did not use ELISA tests as POCT, 2.8 % of other GPs used it. Senior GPs used Hess’s tests significantly more than young GPs (35% vs 20%). WHO-Clinical-criteria+ outbreak information with RDT tests were more used by young GPs, but it was not statistically significant. Following clinical guideline, confirmation of cases, easy to perform, cost and market availability were reasons given for using the tests. Conclusion: Low utilization of dengue diagnostic tests highlighted to promote adherence of W.H.O recommendation among Myanmar GPs. POCT training should be arranged. A further study is needed for more valid findings

Performance and feasibility of reactive surveillance and response strategies for malaria elimination in Vietnam: a mixed-methods study

Abstract Background To enhance malaria elimination, Vietnam adopted a Reactive Surveillance and Response (RASR) Strategy in which malaria case notification and investigation must be completed within 2 days followed by a focus investigation within 7 days. The nationwide performance of Vietnam’s RASR strategy has yet to be evaluated. This study aims to evaluate the performance and feasibility of RASR in Vietnam, thereby providing recommendations for improved RASR. Methods To assess malaria RASR in Vietnam, a mixed-methods study of (1) secondary data analysis of nationwide malaria case-based dataset from 2017 to 2021; (2) a quantitative survey, and (3) qualitative in-depth interviews and focus group discussions administered to central, provincial and district level stakeholders/staff and to the commune and community level front line health services providers was conducted. Results In Vietnam, there are guidelines and procedures for implementation of each step of RASR. The completeness of case notification on the reported monthly aggregated data was very high in both the paper-based (12,463/12,498, 99.7% in 2017–2020) and electronic reporting systems (467/467, 100% in 2021 when electronic reporting was introduced); however, there were delays in notification while using the paper-based system (timely notification—7,978/12,498, 63.8%). In 2021, the completeness (453/467, 97.0%) and timeliness (371/467, 79.4%) of case investigation were found to be high. Reactive case detection was the major focus investigation response, with fever screening achievement of 88.6% (11,481 / 12,965) and 88.5% (11,471 / 12,965) among index case and neighbouring household members, respectively. Conclusions Overall, there was policy commitment for implementation of RASR in Vietnam. The completeness and timeliness of case notification and case investigation were high and improved after the introduction of the electronic reporting system. More evidence is required for reactive case detection in defining the screening area or population